Benjamin Garmezy, Medical Oncologist at SCRI Oncology Partners, shared a post on LinkedIn:
“Representation in cancer research is critical to supporting meaningful progress in treating patients throughout every community.
In genitourinary cancers, we advance research by ensuring clinical insights are relevant, applicable, and scalable. Community-based research plays an important role by expanding access and providing a path for studies to better reflect the populations we serve.
Leading into World Cancer Day, I’m proud to be part of Sarah Cannon Research Institute and SCRI Oncology Partners where expanding representation strengthens the scientific evidence that informs cancer care worldwide.”
More posts featuring Benjamin Garmezy.